Empagliflozin Alleviates Renal Ischemia-Reperfusion Injury by Targeting AMPK/NLRP3 Signaling
Transplantation Proceedings
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Empagliflozin Alleviates Renal Ischemia-Reperfusion Injury by Targeting AMPK/NLRP3 Signaling. // Transplantation Proceedings. – URL: https://www.sciencedirect.com/science/article/pii/S0041134526003805?dgcid=rss_sd_all
Empagliflozin Alleviates Renal Ischemia-Reperfusion Injury by Targeting AMPK/NLRP3 Signaling. Transplantation Proceedings. https://www.sciencedirect.com/science/article/pii/S0041134526003805?dgcid=rss_sd_all
“Empagliflozin Alleviates Renal Ischemia-Reperfusion Injury by Targeting AMPK/NLRP3 Signaling.” Transplantation Proceedings.
@article{article98571,
title = {Empagliflozin Alleviates Renal Ischemia-Reperfusion Injury by Targeting AMPK/NLRP3 Signaling},
journal = {Transplantation Proceedings},
url = {https://www.sciencedirect.com/science/article/pii/S0041134526003805?dgcid=rss_sd_all}
}